Medical/Pharmaceuticals News & Press Release Distribution

Medical/Pharmaceuticals

APAC
Global

Glenmark inks agreement with Canadian biotech SaNOtize to commercialize Nitric Oxide Nasal Spray for COVID-19 treatment in India and other Asian markets

* Nitric oxide has antimicrobial properties with direct proven effect on SARS-CoV-2 * Nitric Oxide Nasal Spray (NONS) has been tested in healthy volunteers and patients as part of UK andCanada clinical trials1 MUMBAI, India and VANCOUVER, BC, Aug. 2, 2021 /PRNewswire/ -- Glenmark Pharmaceutic...

2021-08-02 18:45 2769

ElectroPhysiology Frontiers announces appointment of Avi Fischer, M.D. as CEO

MILAN, Aug. 2, 2021 /PRNewswire/ -- ElectroPhysiology Frontiers S.p.A. (EPF), announced that its Board of Directors unanimously appointedAvi Fischer, M.D. as Chief Executive Officer (CEO) of the company and a member of its Board of Directors. EPF is a medical technology company developing an inn...

2021-08-02 18:00 1757

Bionomics Announces Plans to Conduct U.S. Initial Public Offering

ADELAIDE, Australia, Aug. 2, 2021 /PRNewswire/ -- Bionomics Limited (ASX: BNO, OTCQB: BNOEF), (Bionomics) a global, clinical stage biopharmaceutical company, is pleased to announce that it plans to conduct a registered initial public offering of American Depositary Shares (ADSs) in the United ...

2021-08-02 18:00 13699

Hummingbird Bioscience Announces UK MHRA Approval for First-in-Human Phase 1 Trial of HMBD-001 in Advanced Cancers

HOUSTON and SINGAPORE, Aug. 2, 2021 /PRNewswire/ -- Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing precision therapies against hard-to-drug targets, today announced that the UK Medicines and Healthcare Products Regulatory Agency (MHRA) has approved the ...

2021-08-02 17:00 1297

BIOKANGTAI COVID-19 Vaccine Approved for Phase III Clinical Trial in the Philippines

SHENZHEN, China, Aug. 2, 2021 /PRNewswire/ -- On July 30, Shenzhen Kangtai Biological Products Co., Ltd. (BIOKANGTAI) was approved by the Philippine Food and Drug Administration (PFDA) to launch the phase III clinical trial of its independently developed Inactivated COVID-19 Vaccine (Vero cells) ...

2021-08-02 15:25 5015

Envirotainer Welcomes China Southern Airlines as the first mainland China carrier to approve the Releye® RLP

STOCKHOLM, Aug. 2, 2021 /PRNewswire/ -- Envirotainer, the global market leader in secure cold chain solutions for air transportation of pharmaceuticals, today announced that China Southern Airlines has approved the Envirotainer Releye® RLP for usage on their fleet of aircrafts. With this approval...

2021-08-02 14:28 1552

Servier Announces Positive Topline Data from the Global Phase 3 Study of TIBSOVO® (ivosidenib tablets) in Combination with Azacitidine in Patients with Previously Untreated IDH1-mutated Acute Myeloid Leukemia

TIBSOVO is the first targeted therapy to show improved event-free survival and overall survival in combination with azacitidine compared to azacitidine monotherapy. Safety profile consistent with previously published data in patients with IDH1-mutated acute myeloid leukemia. The study recently ...

2021-08-02 14:00 1904

LISCure Biosciences Announces Know-How License Agreement and Stock Purchase Agreement with Mayo Clinic

SEOUL, South Korea, Aug. 1, 2021 /PRNewswire/ -- LISCure Biosciences, Inc. ("LISCure") has entered into a know-how license and development collaboration agreement, and stock purchase agreement with Mayo Clinic to advance LISCure's microbiome therapeutics in non-alcoholic steatohepatitis (NASH). ...

2021-08-02 11:11 1143

Luye Pharma Enters Distribution Agreement with Zuellig Pharma for Seroquel and Seroquel XR in Malaysia and Brunei, Strengthening Business Presence in Asia Pacific and Improving Access to Evidence-Based Medical Treatments for Mental Health

SUBANG JAYA, Malaysia, Aug. 2, 2021 /PRNewswire/ -- Luye Pharma Group today announced that it has entered into an agreement with Zuellig Pharma, a leading healthcare service group inAsia, under which the company grants Zuellig Pharma exclusive rights to distribute its central nervous system drugs...

2021-08-02 10:25 3924

Antengene Announces the Approval of First-in-Class Oral XPO1 Inhibitor Selinexor in South Korea for the Treatment of Relapsed or Refractory Multiple Myeloma and Diffuse Large B-Cell Lymphoma

SEOUL, South Korea and SHANGHAI and HONG KONG, Aug. 2, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in-class therapeutics i...

2021-08-02 07:29 5619

Rey Announces $10 Million in New Series A Funding to Expand Access to Mental Health through Digital Capabilities

Led by Optum Ventures and Oxford Sciences Innovation, new funding will propel Rey's launch of a tech-enabled, on-demand mental health clinic in response to growing demand for high-quality care in an increasingly resource constrained market AUSTIN, Texas, July 31, 2021 /PRNewswire/ -- Rey, a new ...

2021-07-31 02:56 3525

Rey Announces $10 Million in New Series A Funding to Expand Access to Mental Health through Digital Capabilities

Appendix 4C - Q4 FY21 Quarterly Cash Flow Report

Highlights: * Positive Guidance from European Medicines Agency for ATH434 Phase 2 Clinical Trial * Publication in Movement Disorders demonstrates that ATH434 reduces α–synuclein related neurodegeneration in MSA animal model * Presents to MST Access Australian Micro & Small Caps Conference ...

2021-07-30 21:05 14466

China Jo-Jo Drugstores Completes Redomiciliation Merger

HANGZHOU, China, July 30, 2021 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced that th...

2021-07-30 21:00 13928

I-Mab Announces IND Approval by FDA to Initiate Phase 1 Study for Protollin for the Treatment of Alzheimer's Disease

* Planning underway for a Phase 1 Trial to assess new immunotherapy aimed at stimulating the innate immune system to clear beta amyloid protein plaques in Alzheimer's Disease SHANGHAI and GAITHERSBURG, Md., July 30, 2021 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical-stage bio...

2021-07-30 20:00 8577

EC Healthcare and Prenetics Form Strategic Partnership to Pioneer the Future of Medicine

HONG KONG, July 30, 2021 /PRNewswire/ -- EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group inHong Kong, announces that the Group signed a memorandum of understanding with Prenetics Limit...

2021-07-30 15:33 8848

Joint Commission of Taiwan shares Taiwan's experience in smart healthcare

TAIPEI, July 30, 2021 /PRNewswire/ -- The Smart Healthcare Expo Taipei 2021: International Smart Healthcare Forum (Session 1), organized by the Joint Commission ofTaiwan (JCT), was held on July 30, 2021. Designed to promote Taiwan's smart healthcare solutions based on current trends in Malaysi...

2021-07-30 15:30 2043

Joint Commission of Taiwan shares Taiwan's experience in smart healthcare

CliniRx Becomes a Medidata Rave EDC Accredited Partner

SINGAPORE and NEW DELHI, July 30, 2021 /PRNewswire/ -- CliniRx has achieved accreditation as a CRO partner for Medidata Rave EDC, joining Medidata's industry-leading partner program to further advance its technical and oper...

2021-07-30 13:00 2097

Neukio Biotherapeutics completed its $40m Angel round financing, focusing on the development of iPSC-CAR-NK platform and assets.

SHANGHAI, July 30, 2021 /PRNewswire/ -- Neukio Biotherapeutics, a newly established company, recently announced the completion of its$40m Angel round of financing led byLilly Asia Venture (LAV), with the participation of IDG Capital and Sherpa Investments. The fund will be used mainly for the es...

2021-07-30 08:00 2006

Neukio Biotherapeutics completed its $40m Angel round financing, focusing on the development of iPSC-CAR-NK platform and assets.

Global Cord Blood Corporation Files Annual Report on Form 20-F

HONG KONG, July 30, 2021 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced that the Company filed its Annual ...

2021-07-30 04:16 13170

Highlights From The Alzheimer's Association International Conference 2021

DENVER, July 30, 2021 /PRNewswire/ -- Research presented at the Alzheimer's Association International Conference® (AAIC®) 2021 suggests COVID-19 is associated with long-term cognitive dysfunction and acceleration of Alzheimer's disease pathology and symptoms. These studies were among several piec...

2021-07-30 03:44 2420

1 ... 358 359 360361362 363 364 ... 577